Mergers & Acquisitions - Biotechnology, Ophthalmics

Filter

Current filters:

BiotechnologyOphthalmics

Popular Filters

ThromboGenics explores “strategic options” for the company

ThromboGenics explores “strategic options” for the company

24-02-2014

Belgian biotech firm ThromboGenics revealed this morning that it has retained financial advisor Morgan…

AlconBiotechnologyLicensingMergers & AcquisitionsNovartisOphthalmicsThromboGenics

Back to top